Skip to main content
AIFF logo

Firefly Neuroscience, Inc.

AIFFNASDAQTechnologySoftware - Application

$1.02Today:- (-)1Y −56.18%

As of Oct 16, 2026 close

Market cap
$22.64M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.62$3.15
Volume (live)
-
Avg. volume (3M)
5.43M

Firefly Neuroscience (AIFF) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Firefly Neuroscience used $8.19M of cash in operating activities and spent $128.00K on capital expenditures. That left free cash flow of −$8.32M.

Firefly Neuroscience Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Firefly Neuroscience, Inc. (AIFF) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-19.88-10.46-2.60-17.75-4.380.41
Depreciation & Amortization0.170.070.000.220.430.01
Stock Based Compensation0.782.720.300.060.610.00
Change in Working Capital-1.180.450.140.51-0.19-0.03
Change in Accounts Receivable-0.03-0.04-0.070.040.03-0.98
Change in Inventory-0.040.000.000.000.000.00
Change in Accounts Payable-0.630.880.04-0.080.21-0.11
Change in Other Working Capital0.94-0.400.031.360.131.07
Other Operating Activities0.941.070.008.690.130.03
Net Cash from Operating Activities-8.19-6.16-2.17-2.89-3.820.42
Investing Activities
Capital Expenditures-0.13-0.42-0.39-0.540.00-0.06
Acquisitions-2.360.000.000.000.000.00
Sales/Maturities of Investments0.000.00-0.390.001.000.00
Other Investing Activities0.00-0.330.000.260.600.00
Net Cash from Investing Activities-2.49-0.48-0.390.261.60-0.06
Financing Activities
Debt Repayment2.531.960.001.752.040.45
Common Stock Issued9.094.314.641.920.000.01
Other Financing Activities0.000.040.000.000.000.00
Net Cash from Financing Activities11.626.304.642.042.040.46
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.00
Net Change in Cash0.94-0.332.09-0.60-0.180.82
Cash at Beginning of Period1.812.140.060.650.831.04
Cash at End of Period2.751.812.140.060.651.86
Free Cash Flow-8.32-6.57-2.17-2.89-3.820.36
Supplemental Disclosures
Interest Paid-0.01----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Firefly Neuroscience Cash Flow

What is Firefly Neuroscience's free cash flow?

Firefly Neuroscience had negative free cash flow of $8.32M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$8.19M minus $128.00K of capital expenditures.

How much does Firefly Neuroscience spend on capital expenditures?

Firefly Neuroscience spent $128.00K on capital expenditures in fiscal 2025, compared with $415.00K a year earlier.

Does Firefly Neuroscience pay dividends or buy back shares?

Firefly Neuroscience's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition